Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Fuso Pharma, Apr-Jun (1Q) Ordinary Profit Decreases by 29%
4538 Fuso Pharmaceutical Industries,Ltd. 【J-GAAP】
Earnings ReportFuso Pharmaceutical Industries,Ltd. <4538> [TSE Prime] announced its financial results after the market closed on August 8th (15:30). The ordinary profit (non-consolidated) for the first quarter of the fiscal year ending March 2026 (April to June) decreased 28.8% from the same period last year to 0.64 billion yen. Progress toward the plan for the six months ending September (first half) of 1.60 billion yen was 40.4%, also falling below the five-year average of 55.0%.
In the most recent three-month period, from April to June (1Q), the operating profit margin drastically worsened from 7.9% in the same period last year to 3.8%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Jun, 2023 | 13,507 | 589 | 658 | 479 | 54.7 | 59.9 | Aug 9, 2023 | J-GAAP |
| Apr - Jun, 2024 | 14,622 | 1,150 | 909 | 632 | 74.1 | 42.4 | Aug 8, 2024 | J-GAAP |
| Apr - Jun, 2025 | 15,503 | 596 | 647 | 462 | 54.1 | 40.4 | Aug 8, 2025 | J-GAAP |
| YoY | +6.0% | -48.2% | -28.8% | -26.9% | -26.9% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 29,739 | 2,434 | 2,143 | 1,535 | 179.8 | 40 | Nov 11, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 30,600 | 1,600 | 1,600 | 1,100 | 128.8 | 45 | May 9, 2025 | J-GAAP |
| YoY | +2.9% | -34.3% | -25.3% | -28.3% | -28.3% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 55,407 | 1,964 | 1,868 | 1,377 | 160.0 | 70 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 60,563 | 4,131 | 3,780 | -3,288 | -385.0 | 82 | May 9, 2025 | J-GAAP |
| Mar, 2026 Guidance | 61,500 | 3,400 | 3,300 | 2,300 | 269.4 | 90 | May 9, 2025 | J-GAAP |
| YoY | +1.5% | -17.7% | -12.7% | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Jun, 2024 | 14,622 | 1,150 | 909 | 632 | 74.1 | 7.9 | Aug 8, 2024 | J-GAAP |
| Jul - Sep, 2024 | 15,117 | 1,284 | 1,234 | 903 | 105.7 | 8.5 | Nov 11, 2024 | J-GAAP |
| Oct - Dec, 2024 | 16,920 | 1,199 | 1,198 | 867 | 101.5 | 7.1 | Feb 10, 2025 | J-GAAP |
| Jan - Mar, 2025 | 13,904 | 498 | 439 | -5,690 | -666.2 | 3.6 | May 9, 2025 | J-GAAP |
| Apr - Jun, 2025 | 15,503 | 596 | 647 | 462 | 54.1 | 3.8 | Aug 8, 2025 | J-GAAP |
| YoY | +6.0% | -48.2% | -28.8% | -26.9% | -26.9% |
Related Articles
PCI Holdings, Apr-Jun (1Q) Ordinary Profit 337 Million Yen
KIMURATAN, Apr-Jun (1Q) Ordinary Profit Loss Widens
Open Door, Apr-Jun (1Q) Ordinary Profit Loss Widens
FB CARE SERVICE, Apr-Jun (1Q) Ordinary Profit Increases by 9%
Loadstar Capital, Apr-Jun (2Q) Ordinary Profit Decreases by 31%
Meiwa Estate Company, Apr-Jun (1Q) Ordinary Profit Increases by 2.8 times, Exceeds Full-Year Plan
NIHON ISK, First Half Ordinary Profit Decreases by 14%
TAKARA BIO, Apr-Jun (1Q) Ordinary Profit Loss Widens
HOKUYAKU TAKEYAMA, Apr-Jun (1Q) Ordinary Profit Increases by 2%
BENEFIT JAPAN, Apr-Jun (1Q) Ordinary Profit Increases by 75%